© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Asia Pacific

  • Asia Cement’s first convertible bond (CB) sale in five years was priced at the best end of terms for investors, which bankers away from the deal said was “extremely cheap”.
  • BMW Automotive Finance (China) Co is making its first foray into the ABS market this year, with bookbuilding for the Rmb4.5bn ($656m) Bavarian Sky China 2018-1 set to start next Monday.
  • Hong Kong-listed CMBC Capital, a subsidiary of China Minsheng Bank, is targeting Taiwanese bank liquidity for an up to HK$1.4bn ($178m) borrowing.
  • India’s Yes Bank has closed a $400m borrowing, attracting four participants during syndication.
  • Commerzbank has ended a 10-month drought in Singapore dollar-denominated tier two deals, returning this week with a S$400m ($290m) bond. What lies ahead for the southeast Asian city-state’s local currency market? Addison Gong finds out.
  • Chinese state-owned enterprises (SOEs) Poly Real Estate Group Co and China Minmetals Corp took different approaches to pricing their dollar bonds on Monday, resulting in diverging secondary market performances.
  • JP Morgan doubled a tap of its exchangeable bond (EB) linked to shares of Ping An Insurance (Group) Company of China, raising $100m on Monday.
  • OUE Commercial Real Estate Investment Trust will partly fund an acquisition from its sponsor through a S$587.5m ($427.2m) rights issue.
  • August was generally a healthy month for many global derivatives exchanges, though performance was not quite consistent across the industry.
  • Gas asset and infrastructure investment consortium Quadgas made its debut in the sterling corporate bond market on Monday with a £350m 11 year offering. The company had previously raised funds from the US private placement market, but this was its first benchmark public deal.
  • Weak emerging market investor sentiment is dragging on Indonesian high yield bonds, with market watchers blaming the dive on a spill-over effect from other emerging markets. But there are still some silver linings for the island nation.
  • Hua Medicine, the third biotechnology firm to list in Hong Kong, got across the finish line with an undersubscribed retail book, even though several blue-chip funds threw their weight behind the deal.